A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males

NCT00475371 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Healthy Males

Interventions

DRUG: MKC253 Inhalation Powder

Sponsor

Mannkind Corporation